ramycin
Small moleculeexperimental
Fusidic acid, sold under the brand name Fucidin among others, is an antibiotic that is often used topically in creams or ointments and eyedrops but may also be given systemically as tablets or injections. As of October 2008, the global problem of advancing antimicrobial resistance has led to a renewed interest in its use. — Wikipedia
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2017 (NCT03173053)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)C4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O- Mol. weight
- 516.72 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFusidic acid ↗
- ChEMBLCHEMBL383466 ↗
Also known as
- fucidate
- fucidate
- fucidin acid
- fucidin acid
- fusidate
- fusidate
- fusidate
- fusidic acid
- fusidic acid
- fusidine
- fusidine
- ramycin
- ramycin
- ramycin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03173053 | N/A | Aug 1, 2017 | Aalborg University, Radboud University, Sponsor GmbH, University of Amsterdam, University of Copenhagen, ZonMw: The Netherlands Organisation for Health Research and Development |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aalborg University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Radboud University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2017 |
| ZonMw: The Netherlands Organisation for Health Research and Development | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1